nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—CYP1A2—chronic obstructive pulmonary disease	0.38	0.634	CbGaD
SIMEPREVIR—ALB—chronic obstructive pulmonary disease	0.219	0.366	CbGaD
SIMEPREVIR—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0508	0.179	CbGbCtD
SIMEPREVIR—ALB—Prednisone—chronic obstructive pulmonary disease	0.0419	0.147	CbGbCtD
SIMEPREVIR—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0413	0.145	CbGbCtD
SIMEPREVIR—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0279	0.0981	CbGbCtD
SIMEPREVIR—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0266	0.0935	CbGbCtD
SIMEPREVIR—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0237	0.0834	CbGbCtD
SIMEPREVIR—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0232	0.0817	CbGbCtD
SIMEPREVIR—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0219	0.0771	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0139	0.0489	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0131	0.0462	CbGbCtD
SIMEPREVIR—Hepatobiliary disease—Roflumilast—chronic obstructive pulmonary disease	0.00178	0.026	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0222	CcSEcCtD
SIMEPREVIR—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.0183	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.0182	CcSEcCtD
SIMEPREVIR—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.0174	CcSEcCtD
SIMEPREVIR—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.017	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.016	CcSEcCtD
SIMEPREVIR—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.0159	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0151	CcSEcCtD
SIMEPREVIR—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.0151	CcSEcCtD
SIMEPREVIR—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.015	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000955	0.014	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.000883	0.0129	CcSEcCtD
SIMEPREVIR—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000859	0.0126	CcSEcCtD
SIMEPREVIR—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000793	0.0116	CcSEcCtD
SIMEPREVIR—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000785	0.0115	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00078	0.0114	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000771	0.0113	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000771	0.0113	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000755	0.0111	CcSEcCtD
SIMEPREVIR—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000755	0.011	CcSEcCtD
SIMEPREVIR—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000754	0.011	CcSEcCtD
SIMEPREVIR—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00075	0.011	CcSEcCtD
SIMEPREVIR—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000748	0.0109	CcSEcCtD
SIMEPREVIR—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000731	0.0107	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000728	0.0107	CcSEcCtD
SIMEPREVIR—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000722	0.0106	CcSEcCtD
SIMEPREVIR—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000711	0.0104	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000686	0.01	CcSEcCtD
SIMEPREVIR—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000681	0.00997	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00065	0.00951	CcSEcCtD
SIMEPREVIR—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000644	0.00942	CcSEcCtD
SIMEPREVIR—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000634	0.00928	CcSEcCtD
SIMEPREVIR—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000634	0.00928	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00063	0.00921	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00063	0.00921	CcSEcCtD
SIMEPREVIR—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000621	0.00909	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000617	0.00903	CcSEcCtD
SIMEPREVIR—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000604	0.00884	CcSEcCtD
SIMEPREVIR—Infection—Formoterol—chronic obstructive pulmonary disease	0.000604	0.00884	CcSEcCtD
SIMEPREVIR—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000599	0.00876	CcSEcCtD
SIMEPREVIR—Infection—Montelukast—chronic obstructive pulmonary disease	0.000591	0.00865	CcSEcCtD
SIMEPREVIR—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00864	CcSEcCtD
SIMEPREVIR—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00864	CcSEcCtD
SIMEPREVIR—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000578	0.00846	CcSEcCtD
SIMEPREVIR—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00057	0.00834	CcSEcCtD
SIMEPREVIR—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000565	0.00827	CcSEcCtD
SIMEPREVIR—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00816	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000554	0.0081	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000554	0.0081	CcSEcCtD
SIMEPREVIR—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00055	0.00804	CcSEcCtD
SIMEPREVIR—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00055	0.00804	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000542	0.00794	CcSEcCtD
SIMEPREVIR—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.00793	CcSEcCtD
SIMEPREVIR—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00793	CcSEcCtD
SIMEPREVIR—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00788	CcSEcCtD
SIMEPREVIR—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000533	0.0078	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000525	0.00768	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000525	0.00768	CcSEcCtD
SIMEPREVIR—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.00767	CcSEcCtD
SIMEPREVIR—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000524	0.00767	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000523	0.00765	CcSEcCtD
SIMEPREVIR—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00761	CcSEcCtD
SIMEPREVIR—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00761	CcSEcCtD
SIMEPREVIR—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.0076	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000514	0.00752	CcSEcCtD
SIMEPREVIR—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00751	CcSEcCtD
SIMEPREVIR—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.00749	CcSEcCtD
SIMEPREVIR—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00737	CcSEcCtD
SIMEPREVIR—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000503	0.00736	CcSEcCtD
SIMEPREVIR—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.00732	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00725	CcSEcCtD
SIMEPREVIR—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00724	CcSEcCtD
SIMEPREVIR—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00718	CcSEcCtD
SIMEPREVIR—CTSS—respiratory system—chronic obstructive pulmonary disease	0.000482	0.175	CbGeAlD
SIMEPREVIR—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00695	CcSEcCtD
SIMEPREVIR—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00694	CcSEcCtD
SIMEPREVIR—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00694	CcSEcCtD
SIMEPREVIR—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000472	0.0069	CcSEcCtD
SIMEPREVIR—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000447	0.00655	CcSEcCtD
SIMEPREVIR—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00638	CcSEcCtD
SIMEPREVIR—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00638	CcSEcCtD
SIMEPREVIR—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00043	0.00629	CcSEcCtD
SIMEPREVIR—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00043	0.00629	CcSEcCtD
SIMEPREVIR—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00625	CcSEcCtD
SIMEPREVIR—CTSS—connective tissue—chronic obstructive pulmonary disease	0.000425	0.154	CbGeAlD
SIMEPREVIR—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000421	0.00616	CcSEcCtD
SIMEPREVIR—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00603	CcSEcCtD
SIMEPREVIR—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.00594	CcSEcCtD
SIMEPREVIR—CTSS—bronchus—chronic obstructive pulmonary disease	0.000397	0.144	CbGeAlD
SIMEPREVIR—CTSS—smooth muscle tissue—chronic obstructive pulmonary disease	0.000388	0.141	CbGeAlD
SIMEPREVIR—Rash—Formoterol—chronic obstructive pulmonary disease	0.000383	0.00561	CcSEcCtD
SIMEPREVIR—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.00561	CcSEcCtD
SIMEPREVIR—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0056	CcSEcCtD
SIMEPREVIR—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0056	CcSEcCtD
SIMEPREVIR—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00557	CcSEcCtD
SIMEPREVIR—Headache—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00557	CcSEcCtD
SIMEPREVIR—Rash—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00549	CcSEcCtD
SIMEPREVIR—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000375	0.00549	CcSEcCtD
SIMEPREVIR—Headache—Montelukast—chronic obstructive pulmonary disease	0.000373	0.00546	CcSEcCtD
SIMEPREVIR—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.0053	CcSEcCtD
SIMEPREVIR—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00529	CcSEcCtD
SIMEPREVIR—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00528	CcSEcCtD
SIMEPREVIR—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00528	CcSEcCtD
SIMEPREVIR—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00526	CcSEcCtD
SIMEPREVIR—CTSS—trachea—chronic obstructive pulmonary disease	0.000356	0.13	CbGeAlD
SIMEPREVIR—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000354	0.00517	CcSEcCtD
SIMEPREVIR—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00499	CcSEcCtD
SIMEPREVIR—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000298	0.00436	CcSEcCtD
SIMEPREVIR—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00396	CcSEcCtD
SIMEPREVIR—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00595	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.000264	0.00582	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000263	0.00581	CbGpPWpGaD
SIMEPREVIR—CTSS—lung—chronic obstructive pulmonary disease	0.000256	0.0931	CbGeAlD
SIMEPREVIR—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000253	0.00559	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000252	0.00557	CbGpPWpGaD
SIMEPREVIR—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000249	0.00365	CcSEcCtD
SIMEPREVIR—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.00547	CbGpPWpGaD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00363	CcSEcCtD
SIMEPREVIR—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000239	0.00526	CbGpPWpGaD
SIMEPREVIR—Infection—Prednisone—chronic obstructive pulmonary disease	0.000238	0.00348	CcSEcCtD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000234	0.00516	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000232	0.00513	CbGpPWpGaD
SIMEPREVIR—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000232	0.0034	CcSEcCtD
SIMEPREVIR—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00023	0.00508	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00505	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—LY96—chronic obstructive pulmonary disease	0.000226	0.00499	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00022	0.00485	CbGpPWpGaD
SIMEPREVIR—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000218	0.00319	CcSEcCtD
SIMEPREVIR—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000216	0.00317	CcSEcCtD
SIMEPREVIR—CTSS—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000215	0.00473	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000209	0.00462	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000209	0.0046	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000208	0.0046	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.00459	CbGpPWpGaD
SIMEPREVIR—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00304	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00303	CcSEcCtD
SIMEPREVIR—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000206	0.00302	CcSEcCtD
SIMEPREVIR—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00302	CcSEcCtD
SIMEPREVIR—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00299	CcSEcCtD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000199	0.0044	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000197	0.00434	CbGpPWpGaD
SIMEPREVIR—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000195	0.00286	CcSEcCtD
SIMEPREVIR—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000191	0.00422	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00407	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000184	0.00406	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000183	0.00403	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000182	0.004	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000176	0.00389	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000175	0.00385	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000173	0.00382	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.0038	CbGpPWpGaD
SIMEPREVIR—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00251	CcSEcCtD
SIMEPREVIR—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000169	0.00248	CcSEcCtD
SIMEPREVIR—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000166	0.0604	CbGeAlD
SIMEPREVIR—CTSS—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000166	0.00365	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000163	0.00359	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000162	0.00357	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000161	0.00354	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000159	0.00351	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—KL—chronic obstructive pulmonary disease	0.000159	0.00351	CbGpPWpGaD
SIMEPREVIR—Rash—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00221	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000151	0.0022	CcSEcCtD
SIMEPREVIR—Headache—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00219	CcSEcCtD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000149	0.00328	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000145	0.0032	CbGpPWpGaD
SIMEPREVIR—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00208	CcSEcCtD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000135	0.00299	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00299	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000134	0.00295	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000129	0.00285	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	0.000128	0.00283	CbGpPWpGaD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000128	0.00282	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000128	0.00281	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00281	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00281	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00281	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000126	0.00277	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000125	0.00275	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000124	0.00274	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000124	0.00274	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000121	0.00267	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	0.000119	0.00263	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00263	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000119	0.00263	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000117	0.00258	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000114	0.00252	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000114	0.0025	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000112	0.00247	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.00241	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000109	0.00241	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000109	0.0024	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.00238	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000104	0.0023	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000104	0.00229	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.00227	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000103	0.00227	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—TLR2—chronic obstructive pulmonary disease	0.000103	0.00226	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.00224	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.83e-05	0.00217	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	9.67e-05	0.00213	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—KL—chronic obstructive pulmonary disease	9.65e-05	0.00213	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.61e-05	0.00212	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	9.54e-05	0.0021	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	9.29e-05	0.00205	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	9.29e-05	0.00205	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	9.28e-05	0.00205	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	8.93e-05	0.00197	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.87e-05	0.00196	CbGpPWpGaD
SIMEPREVIR—CYP1A2—lung—chronic obstructive pulmonary disease	8.82e-05	0.032	CbGeAlD
SIMEPREVIR—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	8.7e-05	0.00192	CbGpPWpGaD
SIMEPREVIR—ABCB1—respiratory system—chronic obstructive pulmonary disease	8.51e-05	0.0309	CbGeAlD
SIMEPREVIR—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.35e-05	0.00184	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	8.33e-05	0.00184	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	8.14e-05	0.0018	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	8.05e-05	0.00178	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	8e-05	0.00176	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.97e-05	0.00176	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.95e-05	0.00175	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.84e-05	0.00173	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD8A—chronic obstructive pulmonary disease	7.78e-05	0.00172	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	7.59e-05	0.00167	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	7.55e-05	0.00167	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.38e-05	0.00163	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.38e-05	0.00163	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.35e-05	0.00162	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.26e-05	0.0016	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ERBB3—chronic obstructive pulmonary disease	7.23e-05	0.0016	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	7.05e-05	0.00156	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.73e-05	0.00149	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CRP—chronic obstructive pulmonary disease	6.61e-05	0.00146	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.44e-05	0.00142	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.37e-05	0.0014	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—TLR4—chronic obstructive pulmonary disease	6.34e-05	0.0014	CbGpPWpGaD
SIMEPREVIR—ABCB1—trachea—chronic obstructive pulmonary disease	6.29e-05	0.0229	CbGeAlD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6e-05	0.00132	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.97e-05	0.00132	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.97e-05	0.00132	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.91e-05	0.0013	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.87e-05	0.00129	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	5.75e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	5.73e-05	0.00126	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.67e-05	0.00125	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.6e-05	0.00124	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.6e-05	0.00124	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	5.48e-05	0.00121	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	5.48e-05	0.00121	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.48e-05	0.00121	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	5.43e-05	0.0012	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.42e-05	0.0012	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—EGFR—chronic obstructive pulmonary disease	5.4e-05	0.00119	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	5.37e-05	0.00118	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	5.37e-05	0.00118	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.35e-05	0.00118	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.22e-05	0.00115	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	5.18e-05	0.00114	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.16e-05	0.00114	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	5.11e-05	0.00113	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	5.11e-05	0.00113	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	5.1e-05	0.00113	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.09e-05	0.00112	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.03e-05	0.00111	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.02e-05	0.00111	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.85e-05	0.00107	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.83e-05	0.00107	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.79e-05	0.00106	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.79e-05	0.00106	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.71e-05	0.00104	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.68e-05	0.00103	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.65e-05	0.00103	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.61e-05	0.00102	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.59e-05	0.00101	CbGpPWpGaD
SIMEPREVIR—ABCB1—lung—chronic obstructive pulmonary disease	4.52e-05	0.0164	CbGeAlD
SIMEPREVIR—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	4.47e-05	0.000986	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	4.45e-05	0.000982	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	0.000979	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.42e-05	0.000975	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.37e-05	0.000965	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.35e-05	0.00096	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.26e-05	0.00094	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.16e-05	0.000917	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.15e-05	0.000916	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—IL6—chronic obstructive pulmonary disease	4.15e-05	0.000915	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL1B—chronic obstructive pulmonary disease	4.12e-05	0.00091	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.93e-05	0.000867	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.88e-05	0.000855	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.72e-05	0.000821	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.64e-05	0.000802	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.61e-05	0.000797	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.57e-05	0.000787	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.56e-05	0.000786	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.53e-05	0.00078	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.51e-05	0.000775	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.42e-05	0.000755	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.38e-05	0.000746	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.38e-05	0.000745	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.36e-05	0.000741	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.35e-05	0.000739	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.29e-05	0.000725	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.14e-05	0.000693	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—EGFR—chronic obstructive pulmonary disease	3.14e-05	0.000693	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.11e-05	0.000685	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.06e-05	0.000674	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.96e-05	0.000653	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.9e-05	0.000639	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.88e-05	0.000635	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.84e-05	0.000625	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000608	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.75e-05	0.000608	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.68e-05	0.000591	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.62e-05	0.000578	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.000576	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.54e-05	0.000561	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.43e-05	0.000537	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.43e-05	0.000536	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL6—chronic obstructive pulmonary disease	2.42e-05	0.000533	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.4e-05	0.000529	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.39e-05	0.000528	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.36e-05	0.000521	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.35e-05	0.000519	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.3e-05	0.000507	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.3e-05	0.000507	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.23e-05	0.000492	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.2e-05	0.000485	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.18e-05	0.000481	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.16e-05	0.000477	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.15e-05	0.000475	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.15e-05	0.000474	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.14e-05	0.000472	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.05e-05	0.000453	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2e-05	0.000442	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.000419	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.82e-05	0.000402	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.82e-05	0.000402	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.81e-05	0.000399	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.000396	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.78e-05	0.000392	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.77e-05	0.000392	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.74e-05	0.000384	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.000376	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.65e-05	0.000364	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.000357	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.57e-05	0.000347	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.56e-05	0.000343	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.49e-05	0.000329	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.42e-05	0.000313	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000304	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.000289	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.29e-05	0.000285	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000277	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.25e-05	0.000276	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.24e-05	0.000275	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.24e-05	0.000274	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.23e-05	0.000272	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.000271	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000255	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.15e-05	0.000254	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.000252	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.13e-05	0.00025	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.09e-05	0.000241	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000239	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.08e-05	0.000237	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1e-05	0.000221	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.69e-06	0.000214	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	9.58e-06	0.000211	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.5e-06	0.00021	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	9.47e-06	0.000209	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.74e-06	0.000193	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.71e-06	0.000192	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.59e-06	0.000189	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.06e-06	0.000178	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	8e-06	0.000177	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.58e-06	0.000167	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	7.05e-06	0.000156	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.72e-06	0.000148	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.63e-06	0.000146	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	6.46e-06	0.000142	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.18e-06	0.000136	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.18e-06	0.000136	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.85e-06	0.000129	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	5.16e-06	0.000114	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.93e-06	0.000109	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.98e-06	8.78e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.81e-06	8.4e-05	CbGpPWpGaD
